Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy

NCT07260526 · clinicaltrials.gov ↗
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

West China Hospital